{
  "emaEpar": [],
  "fdaDrugLabel": [
    {
      "brand": "PreNatal 19",
      "indication": "INDICATIONS PreNatal 19 chewable tablets are indicated for use in improving the nutritional status of women throughout pregnancy and in postnatal period for both lactating and non-lactating mothers. PreNatal 19 chewable tablets are also useful in improving the nutritional status of women prior to conception.",
      "manufacturer": "Nationwide Laboratories, LLC",
      "splSetId": "198442c8-730a-4635-a496-91e4767714a3"
    }
  ],
  "id": "Beta-Carotene",
  "nciThesaurus": {
    "casRegistry": "7235-40-7",
    "chebiId": "CHEBI:17579",
    "chemicalFormula": "C40H56",
    "definition": "A naturally-occurring retinol (vitamin A) precursor obtained from certain fruits and vegetables with potential antineoplastic and chemopreventive activities.  As an anti-oxidant, beta carotene inhibits free-radical damage to DNA.  This agent also induces cell differentiation and apoptosis of some tumor cell types, particularly in early stages of tumorigenesis, and enhances immune system activity by stimulating the release of natural killer cells, lymphocytes, and monocytes.",
    "fdaUniiCode": "01YAE03M7J",
    "identifier": "C1016",
    "preferredName": "Beta-Carotene",
    "semanticType": "Pharmacologic Substance",
    "subclassOf": [
      "C68303"
    ],
    "synonyms": [
      ".beta.-Carotene",
      "3,7,12,16-tetramethyl-1,18-bis(2,6,6-trimethyl-1-cyclohexenyl)-octadeca-1,3,5,7,9,11,13,15,17-nonaene",
      "BETA CAROTENE",
      "Beta Carotene",
      "Beta-Carotene",
      "Beta-carotene",
      "CAROTENE, BETA",
      "Lumitene",
      "Solatene",
      "beta carotene",
      "beta-Carotene"
    ]
  }
}